Live feed
Filing
SC 13G
SC 13G0000929638-17-000836·MPM Oncology Impact Management GP LLC
Schedule 13G ownership disclosure
Sunesis Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 867328700
Event date: 2017-10-27
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 12.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000929638-17-000836
- Form type
- SC 13G
- Filer
- MPM Oncology Impact Management GP LLC
- CIK
- CIK 1721035
- Filed
- Nov 06, 2017
- Reporting period
- Oct 27, 2017
- Description
- Schedule 13G beneficial ownership